User blogs

The Pharmacovigilance and Drug Safety Software Market which was valued at USD 6.83 billion in 2022, is projected to grow significantly to USD 14.86 billion by 2030, registering a compound annual growth rate (CAGR) of 10.2% over the forecast period from 2023 to 2030. This robust growth is attributed to the rising importance of monitoring drug safety, increasing regulatory requirements, and the expansion of clinical trials globally.Pharmacovigilance software plays a critical role in ensuring drug safe... more